In part two of Dr. Bergenstal's video series on understanding your ambulatory glucose profile (AGP) report, he discusses how to use the information to help your diabetes...

Emerging evidence shows that variability in your A1C level may put you at a higher risk of stroke and heart disease.

Two studies recently published on the Control-IQ and MiniMed 780G systems show that closed-loop automated insulin delivery significantly improves Time in Range.

Two diabetes devices from Medtronic – a next-gen continuous glucose monitor that removes fingerstick calibrations and a smart insulin delivery pen that keeps track of...

Research shows that changes in Time in Range (TIR) affect your mood and that continuous glucose monitoring may help people with diabetes achieve better emotional health.

Time in Range (TIR) is another number for people with diabetes to pay attention to and use to improve their daily diabetes management. We talked with three women in the...

This clinical trial is currently recruiting. Families will participate in weekly sessions that focus on topics related to diabetes distress and parent-teen communication...

Four people from the diabetes community share insights on how and why they use Time in Range in their diabetes management, why it’s so different from relying only on A1C...

COVID-19 vaccines are being distributed in the United States and in many parts of the world. We’re here to answer questions for people with diabetes. Are the vaccines...

Full results from the SURPASS trials on the drug tirzepatide shows that this new medication dramatically lowers A1C and weight and is incredibly effective in people with...

The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the...

The American Diabetes Association’s 81st Scientific Sessions is going strong. Updates from days two and three include promising Omnipod 5 results, Medtronic’s seven-day...

We bring you the most exciting news from day one of the 81st ADA Scientific sessions, including updates on inhaled insulin, digital diabetes management programs,...

Zegalogue emergency glucagon comes as a pre-filled injection or auto-injector pen and can be used to treat severe hypoglycemia quickly.

Nick Jonas, singer, actor, and advocate for people with diabetes, is launching The Global Movement for Time in Range, an educational ad campaign to raise awareness for...

We’ve reviewed the latest research to weigh the benefits and drawbacks of intermittent fasting and time-restricted feeding for people with diabetes.

A remote six-month clinical trial is recruiting 150 children between the ages of two to five whose families are interested in trying automated insulin delivery. The...

The discovery of insulin promised a new age for an ancient condition but introduced unexpected challenges. James S. Hirsch explores the riveting history of this miracle...

The latest innovations in diabetes technology have brought Time in Range (TIR) to the forefront of diabetes care. Read to learn about the most exciting TIR news from one...

From automated insulin delivery to therapeutic advances to glucose management during COVID-19, read our full coverage of one of the biggest international virtual...